Saffron: An Old Medicinal Plant and a Potential Novel Functional Food
María José Bagur, Gonzalo Alonso Salinas, Antonia Jiménez-Monreal et al. · Molecules · 2017 · Review
Full textCC BY
Medicine: papers
Filters2 filters applied
26 papersQuestions on this topic
Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology
Lucie Thorel, Marion Perréard, Romane Florent et al. · Experimental & Molecular Medicine · 2024 · Review
Full textCC BY
NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
Enzo Alessio, Luigi Messori · Molecules · 2019 · Review
Full textCC BY
Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine
Jake R. Conway, Eric Kofman, Shirley S. Mo et al. · Genome Medicine · 2018 · Review
Full textCC BY
Anti-PD-1/PD-L1 Therapy for Non-Small-Cell Lung Cancer: Toward Personalized Medicine and Combination Strategies
Hongshu Sui, Ningxia Ma, Ying Wang et al. · Journal of Immunology Research · 2018 · Review
Full textCC BY
Immune Checkpoint Inhibitors for Lung Cancer Treatment: A Review
Keisuke Onoi, Yusuke Chihara, Junji Uchino et al. · Journal of Clinical Medicine · 2020 · Review
Full textCC BY
Clinical development of targeted and immune based anti-cancer therapies
N. A. Seebacher, A. E. Stacy, G. M. Porter et al. · Journal of Experimental & Clinical Cancer Research · 2019 · Review
Full textCC BY
The Role of Cancer-Associated Fibroblasts in Tumor Progression
Rushikesh S. Joshi, Samanvi S. Kanugula, Sweta Sudhir et al. · Cancers · 2021 · Review
Full textCC BY
Pharmacological Effects of Cisplatin Combination with Natural Products in Cancer Chemotherapy
Shaloam Dasari, Sylvianne Njiki, Ariane Mbemi et al. · International Journal of Molecular Sciences · 2022 · Review
Full textCC BY
Prognostic Value of Neutrophil-to-Eosinophil Ratio (NER) in Cancer: A Systematic Review and Meta-Analysis
Taha Koray Sahin, Ruveyda Ayasun, Alessandro Rizzo et al. · Cancers · 2024 · Review
Full textCC BY
The Latest Battles Between EGFR Monoclonal Antibodies and Resistant Tumor Cells
Wen-Qi Cai, Li-Si Zeng, Li-Feng Wang et al. · Frontiers in Oncology · 2020 · Review
Full textCC BY
Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels
Khushbu Rauniyar, Sawan Kumar Jha, Michael Jeltsch · Frontiers in Bioengineering and Biotechnology · 2018 · Review
Full textCC BY
CAR T therapies in multiple myeloma: unleashing the future
Mohsen Sheykhhasan, Amirhossein Ahmadieh-Yazdi, Rosario Vicidomini et al. · Cancer Gene Therapy · 2024 · Review
Full textCC BY
The WISDOM Study: breaking the deadlock in the breast cancer screening debate
Laura J. Esserman, the WISDOM Study and Athena Investigators, Hoda Anton-Culver et al. · npj Breast Cancer · 2017 · Review
Full textCC BY
The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
Florent Petitprez, Maxime Meylan, Aurélien de Reyniès et al. · Frontiers in Immunology · 2020 · Review
Full textCC BY
SOX2 and cancer: current research and its implications in the clinic
Kasia Weina, Jochen Utikal · Clinical and Translational Medicine · 2014 · Review
Full textCC BY
Tumour macrophages as potential targets of bisphosphonates
Thea L Rogers, Ingunn Holen · Journal of Translational Medicine · 2011 · Review
Full textCC BY
Epithelial-Mesenchymal Transition and Breast Cancer
Yanyuan Wu, Marianna Sarkissyan, Jaydutt Vadgama · Journal of Clinical Medicine · 2016 · Review
Full textCC BY
Cell therapies in the clinic
Lily Li‐Wen Wang, Morgan E. Janes, Ninad Kumbhojkar et al. · Bioengineering & Translational Medicine · 2021 · Review
Full textCC BY
DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities
Yasser Abuetabh, H. Helena Wu, Chengsen Chai et al. · Experimental & Molecular Medicine · 2022 · Review
Full textCC BY